Literature DB >> 17449990

Opioids: after thousands of years, still getting to know you.

Nathaniel Katz1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17449990     DOI： 10.1097/AJP.0b013e31803cb905

Source DB:  PubMed          Journal:  Clin J Pain        ISSN： 0749-8047            Impact factor:   3.442


× No keyword cloud information.
  6 in total

1.  Trends in long-term opioid therapy for chronic non-cancer pain.

Authors:  Denise Boudreau; Michael Von Korff; Carolyn M Rutter; Kathleen Saunders; G Thomas Ray; Mark D Sullivan; Cynthia I Campbell; Joseph O Merrill; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Pharmacoepidemiol Drug Saf       Date:  2009-12       Impact factor: 2.890

2.  De facto long-term opioid therapy for noncancer pain.

Authors:  Michael Von Korff; Michael Von Korff; Kathleen Saunders; Gary Thomas Ray; Denise Boudreau; Cynthia Campbell; Joseph Merrill; Mark D Sullivan; Carolyn M Rutter; Michael J Silverberg; Caleb Banta-Green; Constance Weisner
Journal:  Clin J Pain       Date:  2008 Jul-Aug       Impact factor: 3.442

3.  The promotion and marketing of oxycontin: commercial triumph, public health tragedy.

Authors:  Art Van Zee
Journal:  Am J Public Health       Date:  2008-09-17       Impact factor: 9.308

Review 4.  Addressing the intersecting problems of opioid misuse and chronic pain treatment.

Authors:  Richard A Denisco; Redonna K Chandler; Wilson M Compton
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

5.  Patient Experiences With Integrated Pain Care: A Qualitative Evaluation of One VA's Biopsychosocial Approach to Chronic Pain Treatment and Opioid Safety.

Authors:  Natalie Purcell; Kara Zamora; Carolyn Gibson; Jennifer Tighe; Jamie Chang; Joseph Grasso; Karen H Seal
Journal:  Glob Adv Health Med       Date:  2019-04-22

6.  Number Of Clinical Trial Study Sites Impacts Observed Treatment Effect Size: An Analysis Of Randomized Controlled Trials Of Opioids For Chronic Pain.

Authors:  Diana S Meske; Ben J Vaughn; Ernest A Kopecky; Nathaniel Katz
Journal:  J Pain Res       Date:  2019-11-20       Impact factor: 3.133
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.